top of page

What's the Latest
PFCD Celebrates Passage of PBM Reforms Critical to Lowering Costs and Improving Outcomes for Americans with Chronic Disease
February 4, 2026 (WASHINGTON, D.C.) The Partnership to Fight Chronic Disease (PFCD) applauds the passage of the Consolidated Appropriations Act of 2026 and its inclusion of many important health care elements that support efforts to better prevent and manage costly chronic conditions. Notably, the bill will increase transparency and lower health care costs for people living with one or more chronic conditions by instituting much needed reforms for pharmacy benefit managers (
Feb 3
Medicare Drug Pricing Must Not Create New Barriers for People Living with Chronic Disease
January 28, 2026 (Washington, D.C.) The Partnership to Fight Chronic Disease (PFCD) released the following statement in response to the Centers for Medicare & Medicaid Services (CMS) announcement of 15 new drugs selected for price-setting in Initial Price Applicability Year (IPAY) 2028: “Prescription medicines are a cornerstone of chronic disease management for Medicare beneficiaries, the vast majority of whom rely on one or more medications every month to maintain their hea
Jan 27
Chronic Disease is Straining U.S. Health Care, and Insurers Aren’t Helping
Chronic conditions are the primary driver of rising U.S. health care spending across Medicare, Medicaid and private insurance, a new study from the Partnership to Fight Chronic Disease (PFCD) detailed last week. Costs are highly concentrated among patients living with three or more chronic conditions, and obesity plays a central role . PFCD Chair Kenneth Thorpe, PhD., and Peter Joski authored the new research report , which is particularly relevant leading up to two House hea
Jan 21
New Analysis Links Obesity and Multiple Chronic Conditions to Unsustainable Spending Growth Across Insurance Programs
January 14, 2026 (Washington, D.C.) The Partnership to Fight Chronic Disease (PFCD) today released a new research report, “ The Association of Obesity and Chronic Conditions Treated as it Relates to the Growth in Health Care Spending by Source of Insurance, 2011–2022 ,” by PFCD Chair Kenneth E. Thorpe and Peter J. Joski. The report finds that the increasing prevalence of obesity and multiple chronic conditions is the dominant force behind rising health care spending across M
Jan 14
PFCD Statement on Mandatory Medicare Demos Implementing Most Favored Nation Drug Pricing
December 19, 2025 (WASHINGTON, D.C.) The Partnership to Fight Chronic Disease (PFCD) released the following statement today in response to the Centers for Medicare and Medicaid Services (CMS) announcement of mandatory demonstration projects that would implement Most Favored Nation (MFN) drug pricing in Medicare Parts B and D: “PFCD remains opposed to a MFN approach to drug price-setting that would import foreign price controls, threaten patient access, pose ethical concerns,
Dec 19, 2025
New Report: Chronic Disease Could Cost the U.S. $47 Trillion Over Next 15 Years
Multiple Chronic Conditions a Key Driver of Unsustainable Spending Growth December 18, 2025 (Washington, D.C.) New national and state data released today by the Partnership to Fight Chronic Disease (PFCD) projects that chronic disease is on pace to cost the United States as much as $47 trillion between 2024 and 2039, including $2.2 trillion annually in medical costs and nearly $900 billion each year in lost productivity by 2039 . The analysis, conducted by GlobalData, highli
Dec 18, 2025
bottom of page
